PFE  Pfizer Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

208.40B

Vuru Grade

60.55/100

Current Price

$33.76
+0.96 (+2.93%)

Growth Price

$25.25
Overvalued by 25.20%

Stability Price

$11.77
Overvalued by 65.12%

Company Metrics

  • P/E 30.36
  • P/S 4.14
  • P/B 3.03
  • EPS 1.11
  • Cash ROIC 13.13%
  • Cash Ratio 0.79
  • Dividend 1.2 / 3.67%
  • Avg. Vol. 48.77M
  • Shares 6.17B
  • Market Cap. 208.40B

Company Description

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segment's provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diab... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

9 Figures That Sum Up Pfizer, Inc.'s First Quarter
Motley Fool - 13 hours ago
Investors wondering if Pfizer's shares should be bought or sold on this news might want to consider these nine numbers, each of which offers additional insight into whether the company is worth owning in your portfolio. 15%. Ex-out the impact of last ...
Is Pfizer Inc. Finally Safe To Buy Again? (PFE) - Investorplace.com
Pfizer Inc. (PFE) Tops Earnings Estimates With 20% Jump In Q1 Revenue - International Business Times
Tuesday's Vital Data: Baidu Inc (ADR) (BIDU), Pfizer Inc. (PFE) and Valeant ...
Investorplace.com - 22 hours ago
U.S. stock futures are trading sharply lower heading into the open this morning, as weak Chinese economic data and an Australian interest-rate cut fueled fears of a weakening global economy.
Why Fidelity National Information Services (FIS), Pfizer Inc. (PFE) and Yelp ...
Investorplace.com - 14 hours ago
Why Fidelity National Information Services (FIS), Pfizer Inc. (PFE) and Renewed concerns about global economic growth sent investors scurrying into favored safe-haven assets, namely U.S.
Earnings Whispers: Pfizer Inc. (PFE), Halliburton Company (HAL) & CVS Health ...
Daily Caller - 23 hours ago
Pfizer Inc. (NYSE:PFE), Halliburton Company (NYSE:HAL), and CVS Health Corp (NYSE:CVS) are about to report their first quarter financials in pre-market hours today.
Keep an Eye on These 12 Stocks for May 3, 2016 - Benzinga
Earnings Reaction History: Pfizer Inc, 40.0% Follow-Through Indicator, 1.4 ...
Nasdaq - May 3, 2016
Pfizer Inc ( PFE ) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement.
Pfizer Inc. Q1 Profit Climbs 30%
Nasdaq - May 3, 2016
(RTTNews.com) - Pfizer Inc. ( PFE ) released earnings for its first quarter that climbed from last year. The company said its bottom line came in at $4.16 billion, or $0.67 per share.
Pfizer Inc Vs. Merck & Co: Which Pharmaceutical Giant Should You Buy?
Seeking Alpha - May 2, 2016
Two mega-cap pharma plays which have attracted my attention for some time are Pfizer (NYSE:PFE) and Merck & Co (NYSE:MRK).
Merck And Pfizer Earnings: Will They Beat Expectations Again? - Benzinga
BRIEF-Pfizer Inc reports Q1 adjusted earnings per share $0.67
Reuters - May 3, 2016
May 3 Pfizer Inc. * Reports First Quarter 2016 results. * Q1 adjusted earnings per share $0.67. * Q1 earnings per share view $0.55 -- Thomson Reuters I/B/E/S.
Medivation Inc M&A Talk: Pfizer Inc Might Be a Contender
Bidness ETC - May 2, 2016
If Sanofi SA (ADR) (NYSE:SNY) does plan to aggressively pursue Medivation for takeover, it might face tough competition. Soon after the sought-after biotech company rejected Sanofi's $9.3 billion takeover bid on Friday, Bloomberg reported, citing ...
Exclusive: Pfizer approaches Medivation about potential takeover - sources - Reuters
Pfizer said to ponder Medivation acquisition - MarketWatch
Pfizer Inc (PFE) Closes 0.28% Up on the Day for May 02
Equities.com - May 2, 2016
Pfizer Inc currently has a total float of 6.18 billion shares and moves 52.38 million a day, on average. The stock opened at $32.56 on May 02 and traded between a low of $32.50 and a high of $33.00.